Received Mar 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 945660 | IM / RA |
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 7L3ST | IM / LA |
Patient reports one week after injection that she had a rash over all of her body.
None
No known
No known
Patient states that she went into the ER for cream due to rash.